Stephen M. Hahn, M.D.
Stephen M. Hahn, M.D.
Henry K. Pancoast Professor of Radiation Oncology
Department: Radiation Oncology
Contact information
Perelman Center for Advanced Medicine
TRC 2 West
34th and Civic Center Boulevard
Philadelphia, PA 19104
TRC 2 West
34th and Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-7296
Fax: 215-349-5923
Fax: 215-349-5923
Email:
steve.hahn@uphs.upenn.edu
steve.hahn@uphs.upenn.edu
Education:
B.A. (Biology)
Rice University , 1980.
M.D. (Medicine)
Temple University, 1984.
Permanent linkB.A. (Biology)
Rice University , 1980.
M.D. (Medicine)
Temple University, 1984.
Selected Publications
Xanthopoulos, E.P., Corradetti, M.N., Mitra, N., Fernandes, A.T., Kim, M., Grover, S., Christodouleas, J.P., Evans, T.L, Stevenson, J.P., Langer, C.J., Lee, T.T., Pryma, D.A., Lin, L.L., Simone, II, C.B., Apisarnthanarax, S., and Rengan, R.: Impact of PET staging in limited-stage small-cell lung cancer. J Thorac Oncol May 2013.Gray, P.J., Paly, J.J., Yeap, B.Y., Sanda, M.G., Sandler, H.M., Michalski, J.M., Talcott, J.A., Coen, J.J., Hamstra, D.A., Shipley, W.U., Hahn, S.M., Zietman, A.L., Bekelman, J.E., Efstathiou, J.A.: Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer Feb 2013.
Bekelman, J.E. and Hahn, S.M.: The body of evidence for advanced technology in radiation oncology. J Natl Cancer Inst 105(1): 6-7, Jan 2013.
Jagsi, R., Bekelman, J.E., Brawley, O.W., Deasy, J.O., Le, Q., Michalski, J.M., Movsas, B., Thomas, C.R., Lawton, C.A., Lawrence, T.S., and Hahn, S.M.: A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys 84(2): 318-22, Oct 2012.
Lin, L.L., Silvoniemi, A., Stubbs, J.B., Rengan, R., Suilamo, S., Solin, O., Divgi, C., Eskola, O., Sorger, J.M., Stabin, M.G., Kachur, A., Hahn, S.M., Grönroos, T.J., Forsback, S., Evans, S.M., Koch, C.J., and Minn, H.: Radiation dosimetry and biodistribution of the hypoxia tracer ¹⁸F-EF5 in oncologic patients. Cancer Biother Radiopharm 27(7): 412-9, Sep 2012.
Lin, A. and Hahn, S.M.: Hypoxia imaging markers and applications for radiation treatment planning. Semin Nucl Med 42(5): 343-52, Sep 2012.
Friedberg, J.S., Culligan, M.J., Mick, R., Stevenson, J., Hahn, S.M., Sterman, D., Punekar, S., Glatstein, E., and Cengel, K.: Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 93(5): 1658-65; discussion 1665-7, May 2012.
Shah, A., Efstathiou, J.A., Paly, J.J., Halpern, S.D., Bruner, D.W., Christodouleas, J.P., Coen, J.J., Deville, C., Vapiwala, N., Shipley, W.U., Zietman, A.L., Hahn, S.M., and Bekelman, J.E.: Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 83(1): e13-9, May 2012.
Rengan, R., Mick, R., Pryma, D., Rosen, M.A., Lin, L.L., Maity, A.M, Evans, T.L., Stevenson, J.P., Langer. C.J., Kucharczuk, J., Friedberg, J., Prendergast, S., Sharkoski, T., and Hahn, S.M.: A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol 7(4): 709-15, Apr 2012.
Worni, M., Akushevich, I., Gloor, B., Scarborough, J., Chino, J.P., Jacobs, D.O., Hahn, S.M., Clary, B.M., Pietrobon, R., and Shah, A.: Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Annals of Surgical Oncology 19(4): 1316-23, Apr 2012.